Kenneth Swart
About Kenneth Swart
Kenneth Swart serves as the Senior Vice President of Bioanalytical and Biotherapeutic Sciences at Inotiv, where he has worked since 2021. He has a long history in the biopharmaceutical industry, including co-founding a CRO, leading biomarker services at PAREXEL, and holding academic positions at the University of the Free State.
Work at Inotiv
Kenneth Swart currently serves as the Senior Vice President of Bioanalytical and Biotherapeutic Sciences at Inotiv, a position he has held since 2021. His role involves overseeing bioanalytical services and biotherapeutic development, contributing to the company's mission of advancing drug development processes. Prior to this, he worked as the Vice President of Bioanalytical Science and Biotherapeutics at Inotiv for a brief period in 2021. His extensive experience in the field enhances Inotiv's capabilities in delivering high-quality analytical services.
Education and Expertise
Kenneth Swart holds a PhD in Pharmacology, Bioanalytical Chemistry, Chemistry, and Physiology from the University of the Free State, where he studied from 1973 to 1987. He also completed his Matriculated education at Grey College. His academic background provides a strong foundation for his expertise in bioanalysis and biotherapeutics, which he has applied throughout his career in various leadership roles within the industry.
Background
Kenneth Swart co-founded a full-service contract research organization (CRO) in 1985, which was later acquired by PAREXEL in 2000. He has held multiple positions at PAREXEL, including Worldwide Head of Bioanalysis and Biomarker Services from 2004 to 2010 and Senior Director and Subject Matter Expert in Bioanalysis, Biomarkers, and Genomic Medicine from 2010 to 2021. His career spans several countries, including South Africa and the United States, where he has contributed significantly to the field of bioanalytical sciences.
Achievements
Kenneth Swart has published over 39 articles in peer-reviewed journals, showcasing his contributions to scientific literature in the field of bioanalysis and biotherapeutics. In 2008, he received an award from the National Science and Technology Forum for his outstanding contribution to science, engineering, and innovation in South Africa. Additionally, he served on the Editorial Advisory Board of the Journal of Chromatographia, further demonstrating his influence and expertise in the scientific community.